BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NDNR - Naturopathic Doctor News and Review - ECPv6.17.5//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:NDNR - Naturopathic Doctor News and Review
X-ORIGINAL-URL:https://ndnr.com
X-WR-CALDESC:Events for NDNR - Naturopathic Doctor News and Review
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20140101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20151022T130000
DTEND;TZID=UTC:20151022T143000
DTSTAMP:20150925T033943Z
CREATED:20150925T033943Z
LAST-MODIFIED:20150925T033943Z
UID:16035-1445518800-1445524200@ndnr.com
SUMMARY:How Biography Becomes Biology
DESCRIPTION:Mindful Healing: Connecting the Cell & the Self 7 – Part Webinar\n\n\n\nDis-ease tells a story\, not just about our cells and a diagnosis\, but of ourselves and our lives. It is becoming increasingly clear that the Mind-Body Connection is critically important in a holistic and integrative practice of medicine.\n\n\nThis 7-week webinar course will integrate the study\, practice\, and clinical application of mindfulness and a variety of powerful\, mind-body therapies. \n\n\nSession Topics: \n\n\nOct 15 –   Becoming a Mindful Practitioner \n\nOct 22 –   How Biography Becomes Biology\nOct 29 –   Guided Imagery: Listening to the\nSymptom\nNov  5  –  Guided Imagery: Listening to the Inner\nAdvisor\nNov 12 –  Childhood Trauma & Adult Disease\nNov 19 –  Healing Presence & the Therapeutic\nRelationship\nDec 10 –  Clinical Application and Integration\n\n\nClick here for more information and to register.
URL:https://ndnr.com/event/how-biography-becomes-biology/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20151022T200000
DTEND;TZID=UTC:20151022T213000
DTSTAMP:20151014T053902Z
CREATED:20151014T053902Z
LAST-MODIFIED:20151014T053902Z
UID:16851-1445544000-1445549400@ndnr.com
SUMMARY:Non-Alcoholic Fatty Liver Disease (NAFLD): Epidemiology\, Pathophysiology\, Diagnosis and Treatment
DESCRIPTION:Current research indicates that the prevalence and impact of NAFLD is continuing to increase\, making NASH potentially the most common cause of advanced liver disease in coming decades. \nThe term NAFLD encompasses a wide range of conditions\, ranging from macrovesicular steatosis\, NASH which is fatty liver with inflammation\, fibrosis\, and cirrhosis. NASH represents the more severe end of the spectrum of non-alcoholic fatty liver disease and differs from the simple accumulation of fat in the liver\, which has a more vague set of symptoms and diagnostic criteria.\nHowever\, NAFLD is associated with higher levels of glycated haemoglobin\, triglyceride: high density lipoprotein cholesterol ratio\, insulin resistance\, and liver enzymes (alanine aminotransferase\, aspartate aminotransferase\, and y-glutamyltransferase). NAFLD is universally considered as the hepatic manifestation of the metabolic syndrome (MS) and insulin resistance is regarded as its key pathophysiological hallmark. Symptoms of NAFLD are vague\, but it has a strong association with central obesity\, reduced glucose tolerance\, type 2 diabetes mellitus\, arterial hypertension and hypertriglyceridaemia. \nTo register\, please visit www.seroyal.com/education/programs-and-courses/non-alcoholic-fatty-liver-disease-nafld-epidemiology-pathophysiology-diagnosis-and-treatment.html \n†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose\, treat\, cure\, or prevent any disease.
URL:https://ndnr.com/event/non-alcoholic-fatty-liver-disease-nafld-epidemiology-pathophysiology-diagnosis-and-treatment/
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR